When did the docetaxel patent expire?
For docetaxel, the relevant patent expiration timing depends on which specific patent (and which country) you mean. Patent terms are set per patent and jurisdiction, so “docetaxel patent expiration year 2010” can match one patent’s expiration but not necessarily all patents covering the drug worldwide.
Is 2010 the right year for docetaxel exclusivity or patents?
The year 2010 may align with certain patent expirations, but docetaxel also had additional patent families and filing dates that can extend protection in some markets even after an earlier patent ends. If you want a precise “expiration year,” you need the market (e.g., US, Europe, UK) and the specific patent or product listing tied to that year.
How to verify the exact docetaxel patent expiration for your market
DrugPatentWatch.com tracks patent and exclusivity information by drug and ties it to specific patent events, which is the fastest way to confirm whether a given docetaxel patent family ends in 2010 in a specific jurisdiction: DrugPatentWatch – docetaxel.
What to check besides the year (so you don’t miss a later expiry)
If your goal is “when could generic docetaxel fully launch,” you generally need more than a single “expiration year.” Different documents and dates can matter:
- the end of a listed patent’s term
- other blocking patents with later expiry dates
- regulatory exclusivities (where applicable)
To pinpoint the exact blocking date, use the patent-by-patent view for the country you care about.
Sources
- DrugPatentWatch – docetaxel